We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUI icon
751
Sun Communities
SUI
$15.1B
$9.29M 0.02%
91,364
+3,599
+4% +$367K
FLS icon
752
Flowserve
FLS
$9.78B
$9.29M 0.02%
244,284
+310
+0.1% +$14.5K
SNV
753
DELISTED
Synovus
SNV
$9.28M 0.02%
290,122
+70,503
+32% +$2.66M
AGCO icon
754
AGCO
AGCO
$7.28B
$9.28M 0.02%
166,697
+52,044
+45% +$2.94M
AMED
755
DELISTED
Amedisys
AMED
$9.26M 0.02%
79,058
+13,414
+20% +$1.58M
AAN.A
756
DELISTED
The Aaron's Company Inc Class A
AAN.A
$9.25M 0.02%
220,007
+88,848
+68% +$3.74M
CHDN icon
757
Churchill Downs
CHDN
$5.82B
$9.2M 0.02%
226,320
+85,452
+61% +$3.77M
LGND icon
758
Ligand Pharmaceuticals
LGND
$5.85B
$9.17M 0.02%
108,348
+25,511
+31% +$2.72M
CVSA
759
Covista Inc
CVSA
$4.34B
$9.17M 0.02%
193,740
+79,459
+70% +$4.06M
HWC icon
760
Hancock Whitney
HWC
$6.26B
$9.16M 0.02%
264,284
+96,968
+58% +$3.93M
COR
761
DELISTED
Coresite Realty Corporation
COR
$9.15M 0.02%
104,889
+25,459
+32% +$2.47M
CBU icon
762
Community Bank
CBU
$3.5B
$9.12M 0.02%
156,486
+26,557
+20% +$1.6M
DISH
763
DELISTED
DISH Network Corp.
DISH
$9.11M 0.02%
364,840
-3,679
-1% -$115K
HCSG icon
764
Healthcare Services Group
HCSG
$1.61B
$9.08M 0.02%
226,063
+83,839
+59% +$3.54M
HP icon
765
Helmerich & Payne
HP
$3.41B
$9.06M 0.02%
188,909
-463
-0.2% -$28.4K
ATI icon
766
ATI
ATI
$26.4B
$9.04M 0.02%
415,396
+171,303
+70% +$4.44M
AMG icon
767
Affiliated Managers Group
AMG
$10.1B
$9.04M 0.02%
92,789
-7,537
-8% -$851K
BG icon
768
Bunge Global
BG
$20.2B
$9.02M 0.02%
168,748
+2,009
+1% +$124K
WWW icon
769
Wolverine World Wide
WWW
$1.62B
$8.99M 0.02%
281,986
+46,896
+20% +$1.6M
CPRI icon
770
Capri Holdings
CPRI
$1.88B
$8.98M 0.02%
236,904
-3,491
-1% -$176K
FDC
771
DELISTED
First Data Corporation
FDC
$8.94M 0.02%
528,827
-23,195
-4% -$452K
SF
772
Stifel
SF
$12.7B
$8.93M 0.02%
485,228
+193,329
+66% +$4.01M
HRB icon
773
H&R Block
HRB
$5.73B
$8.93M 0.02%
351,849
-8,842
-2% -$236K
NUS icon
774
Nu Skin
NUS
$251M
$8.92M 0.02%
145,462
+45,585
+46% +$3.07M
VLY icon
775
Valley National Bancorp
VLY
$8.02B
$8.9M 0.02%
1,002,211
+398,986
+66% +$4.03M

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.